Benzene metabolites induce the loss and long arm deletion of chromosomes 5 and 7 in human lymphocytes

Leukemia Research

Volumn 22, Issue 2, 1998, Pages 105-113

  Zhang, Luoping ^a   Wang, Yunxia ^a   Shang, Nong ^a   Smith, Martyn T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

1,2,4 benzenetriol; Aneuploidy; Chromosomal aberrations; FISH; Human leukemia; Hydroquinone

Indexed keywords

1,2,4 BENZENETRIOL; BENZENE; HYDROQUINONE;

ARTICLE; CHROMOSOME 1; CHROMOSOME 5Q; CHROMOSOME 7Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME LOSS; CONTROLLED STUDY; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; LYMPHOCYTE; METABOLITE; METAPHASE; MONOSOMY; MONOSOMY 7; PRIORITY JOURNAL;

EID: 0032006405     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00157-4     Document Type: Article

References (41)

1. 1. Rowley, J., Golomb, H. and Vardiman, J., Nonrandom chromosomal abnormalities in acute non lymphocytic leukemia in patients treated for Hodgkin disease and non-Hodgkin lymphomas. Blood, 1977, 50, 759.
2. 2. Pedersen-Bjergaard, J., Pedersen, M., Roulston, D. and Philip, P., Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood, 1995, 86, 3542.
3. 3. Le Beau, M. M., Espinosa, R. D., Neuman, W. L., Stock, W., Roulston, D., Larson, R. A., Keinanen, M. and Westbrook, C. A., Cytogenic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc. Natl. Acad. Sci. USA, 1993, 90, 5484.
4. 4. Le Beau, M. M., Espinsosa, R. D., Davis, E. M., Eisenbart, J. D., Larson, R. A. and Green, E. D., Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Blood, 1996, 88, 1930.
5. 5. Willman, C. L., Sever, C. E., Pallavicini, M. G., Harada, H., Tanaka, N., Slovak, M. L., Yamamoto, H., Harada, K., Meeker, T. C. and List. A. F. et al., Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science, 1993, 259, 968.
6. 6. Lewis, S., Abrahamson, G., Boultwood, J., Fidler, C., Potter, A. and Wainscoat, J. S., Molecular characterization of the 7q deletion in myeloid disorders. Brirish Journal of Haematology, 1996, 93, 75.
7. 7. Pedersen-Bjergaard, J., Philip, P., Larsen, S. O., Jensen, G. and Byrsting, K., Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood, 1990, 76, 1083.
8. 8. Johansson, B., Mertens, F., Heim, S., Kristoffersson, U. and Mitelman, F., Cytogenetics of secondary myelodysplasia (sMDS) and acute nonlymphocytic leukemia (sANLL). European Journal of Haematology, 1991, 47, 17.
9. 9. Mitelman, F., Nilsson, P. G., Brandt, L., Alimena, G., Gastaldi, R. and Dallapiccola, B., Chromosome pattern, occupation, and clinical features in patients with acute nonlymphocytic leukemia. Cancer Genet. Cytogenet., 1981, 4, 197.
10. 10. Golomb, H. M., Alimena, G., Rowley, J. D., Vardiman, J. W., Testa, J. R. and Sovik, C., Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood, 1982, 60, 404.
11. 11. Crane, M., Strom, S., Halabi, S., Berman, E., Fueger, J., Spitz, M. and Keating, M., Correlation between selected environmental exposures and karotype in acute myelocytic leukemia. Cancer Epidemiology, Biomarkers & Prevention, 1996, 5, 639.
12. 12. Aksoy, M., Benzene Carcinogenicity. CRC Press, Inc., Boca Raton, FL. 1988, pp. 113.
13. 13. Yin, S. N., Hayes, R. B., Linet, M. S., Li, G. L., Dosemeci, M., Travis, L. B., Zhang, Z. N., Li, D. G., Chow, W. H., Wacholder, S. and Blot, W. J., An expanded cohort study of cancer among benzene-exposed workers in China. Benzene Study Group. Environ Health Perspect., Suppl 6, 1996, 104, 1339.
14. 14. Inoue, O., Seiji, K., Kasahara, M., Nakatsuka, H., Watanabe, T., Yin, S. G., Li, G. L., Cai, S. X., Jin, C. and Ikeda, M., Determination of catechol and quinol in the urine of workers exposed to benzene. British Journal of Industrial Medicine, 1988, 45, 4.
15. 15. Smith, M. T., Yager, J. W., Steinmetz, K. L. and Eastmond, D. A., Peroxidase-dependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity. Environ. Health Perspect., 1989, 82, 23.
16. 16. Smith, M. T., The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ. Health Perspect., Suppl 6, 1996, 104, 1219.
17. 17. Erexson, G. L., Wilmer, J. L. and Kligerman, A. D., Sister chromatid exchange induction in human lymphosytes exposed to benzene and its metabolites in vitro. Cancer Research, 1985, 45, 2471.
18. 18. Yager, J. W., Eastmond, D. A., Robertson, M. L., Paradisin, W. M. and Smith, M. T., Characterization of micronuclei induced in human lympocytes by benzene metabolites. Cancer Research, 1990, 50, 393.
19. 19. Robertson, M. L., Eastmond, D. A. and Smith, M. T., Two benzene metabolites, catechol and hydroquinone, produce a synergistic induction of micronuclei and toxicity in cultured human lymphocytes. Mutation Research, 1991. 249, 201.
20. 20. Eastmond, D. A., Induction of micronuclei and aneuploidy by the quinone-forming agents benzene and o-phenylphenol. Toxicology Letters, 1993, 67, 105.
21. 21. Zhang, L., Robertson, M. L., Kolachana, P., Davison, A. J. and Smith, M. T., Benzene metabolite, 1,2,4-benzenetriol, induces micronuclei and oxidative DNA damage in human lymphocytes and HL60 cells. Environ. Mol. Mutagen., 1993, 21, 339.
22. 22. Gray, J. W. and Pinkel, D., Molecular cytogenetics in human cancer diagnosis. Cancer, 1992, 69, 1536.
23. 23. Cremer, T., Lichter, P., Borden, J., Ward, D. C. and Manuelidis, L., Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific library probes. Human Genet., 1988, 80, 235.
24. 24. Hopman, A. H., Moesker, O., Smeets, A. W., Pauwels, R. P., Vooijs, G. P. and Ramaekers, F. C., Numerical chromosome 1,7,9, and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Research, 1991, 51, 644.
25. 25. Poddighe, P. J., Moesker, O., Smeets, D., Awwad, B. H., Ramaekers, F. C. and Hopman, A. H., Interphase cytogenetics of hematological cancer: comparison of classical karyotyping and in situ hybridization using a panel of eleven chromosome specific DNA probes. Cancer Research, 1991, 51, 1959.
26. 26. Jenkins, R. B., Le, B. M., Kraker, W. J., Borell, T. J., Stalboerger, P. G., Davis, E. M., Penland, L., Fernald, A., Espinosa, R. D. and Schaid, D. J. et al., Fluorescence in situ hybridization: a sensitive method for trisomy 8 detection in bone marrow specimens. Blood, 1992, 79, 3307.
27. 27. Wilt, S. R., Burgess, A. C., Normolle, D. P., Trent, J. M. and Lawrence, T. S., Use of fluorescence in situ hybridization (FISH) to study chromosomal damage induced by radiation and bromodeoxyuridine in human colon cancer cells. Int. J. Radiat. Oncol Biol. Phys., 1994, 30, 861.
28. 28. Ellard, S., Parry, E. M. and Parry, J. M., Use of multicolour chromosome painting to identify chromosomal rearrangements in human lymphocytes exposed to bleomycin: a comparison with conventional cytogenetic analysis of Giemsa-stained chromosomes. Environ. Mol. Mutagen., 1995, 26, 44.
29. 29. Zhang, L., Venkatesh, P., Creek, M. L. and Smith, M. T., Detection of 1,2,4-benzenetriol induced aneuploidy and microtubule disruption by fluorescence in situ hybridization and immunocytochemistry. Mutation Research, 1994, 320, 315.
30. 30. Eastmond, D. A., Rupa, D. S. and Hasegawa, L. S., Detection of hyperdiploidy and chromosome breakage in interphase human lymphocytes following exposure to the benzene metabolite hydroquinone using multicolor fluorescence in situ hybridization with DNA probes. Mutation Research, 1994, 322, 9.
31. 31. Tucker, J. D., Lee, D. A., Ramsey, M. J., Briner, J., Olsen, L. and Moore, D. H., On the frequency of chromosome exchanges in a control population measured by chromosome painting. Mutation Research, 1994, 313, 193.
32. 32. Dobson, A. J., An Introduction to Statistical Modeling, Chapman and Hall, New York, 1983.
33. 33. Chambers, J. M., Hastie, T. J., Statistical Models in S, Wadsworth & Brooks/Cole Advanced Books & Software, Pacific Grove, 1992.
34. 34. Irons, R. D. and Stillman, W. S., The process of leukemogenesis. Environ. Health Perspect., Suppl 6, 1996, 104, 1239.
35. 35. Xi, L., Zhang, L., Wang, Y. and Smith, M.T., Induction of chromosome-specific aneuploidy and micronuclei in human lymphocytes by metabolites of 1,3-butadiene. Carcinogenesis, 1997, 18, 1687.
36. 36. Mamuris, Z., Prieur, M., Dutrillaux, B. and Aurias, A., The chemotherapeutic drug melphalan induces breakage of chromosomes rearranged in secondary leukemia. Cancer Genetics and Cyteogenetics, 1989, 37, 65.
37. 37. Maraschin, J., Dutrillaux, B. and Aurias, A., Chromosome abberations induced by etopside (VP-16) are not random, International Journal of Cancer, 1990, 46, 808.
38. 38. Levay, G. and Bodell, W. J., Role of hydrogen peroxide in the formation of DNA adducts in HL-60 cells treated with bezene metabolites. Biochem. Biophys. Res. Commun., 1996, 222, 44.
39. 39. Barale, R., Marrazzini, A., Betti, C., Vangelisti, V., Loprieno, N. and Barrai, I., Genotoxicity of two metabolites of benzene: phenol and hydroquinone show strong synergistic effects in vivo. Mutation Research, 1990, 244, 15.
40. 40. Irons, R. D., Neptun, D. A. and Pfeifer, R. W., Inhibition of lymphocyte transformation and microtube assembly by quinone metabolites of benzene: evidence for a common mechanism. J. Reticuloendothel. Soc., 1981, 30, 359.
41. 41. Kotachana, P., Subrahmanyam, V. V., Meyer, K. B., Zhang, L. and Smith, M. T., Benzene and its phenolic metabolites produce oxidative DNA damage in HL-60 cells in vitro and in the bone marrow in vivo. Cancer Research, 1993, 53, 1023.